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ABSTRACT 
The purpose of my research is to determine if the substitution of selenium for sulfur will 
cause rate acceleration of the thiol-disulfide exchange reaction in the C-terminal redox center of 
Plasmodium falciparum thioredoxin reductase (PfTR) in a position specific manner. P. 
falciparum is the protist that causes most serious form of malaria and is responsible for the 
majority of malaria related deaths. While mammalian thioredoxin reductase (mTR) contains 
selenium in its C-terminal redox center, which accelerates the rate of reaction, PfTR functions in 
the absence of selenium. The results of my studies show that the introduction of selenium via 
selenocysteine to the C-terminal redox center of PfTR impacts the rate of this reaction positively 
when substituted at Cys540 and negatively at Cys535. This data can be explained mechanistically 
by the use of a disulfide electrophilic activation mechanism by PfTR. Specifically, the disulfide 
bond between Cys540 and Cys535 in the C-terminal redox center of PfTR is primed for attack by 
the thiolate of Cys93 of the N-terminal redox center because of a hydrogen bonding interaction 
between Cys535 and an adjacent histidine residue. This interaction polarizes the Cys540–Cys535 
disulfide, making the sulfur atom of Cys540 highly electrophilic. The differential effects on rate 
caused by selenium substitution of each of the two sulfur atoms of the C-terminal disulfide 
represents a “seleno effect”, similar to the observed “thio effect” in phosphodiesterases when 
sulfur substitutes for oxygen in non-bridging oxygen atoms of phosphodiesters. Thioredoxin 
reductase is essential in all organisms and its loss of function is deadly for the host. Due to the 
differences in structure between PfTR and mTR, the mechanism proposed represents a potential 
drug target in the fight against malaria. 
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The Thioredox System 
The thioredoxin system is comprised of the small protein thioredoxin (Trx), thioredoxin 
reductase (TR), and NADPH. The components and function of this system is described in the 
following sections. 
Thioredoxin.  
Thioredoxin (Trx) is a class of small disulfide-containing oxidoreductases that is 
ubiquitous from archaea to humans.1 The TRX gene encodes the human variant of the protein, 
and a loss of function mutation of this gene is lethal at the four cell stage of development.2, 3 Trx 
is a 12KD highly conserved protein and has multiple functions including 1) facilitating thiol-
disulfide exchange between itself and a target protein 2) donating electrons to target proteins and 
3) quenching reactive oxygen species (ROS) as an antioxidant.4 Its redox exchange capability is 
essential to many different processes throughout all cells and new systems are continually being 
discovered in which Trx plays a role. It has been found to be involved in regulation of metabolic 
pathways via redox signaling as well as through its control of oxidative stress.5, 6 The defining 
trait of Trx is the presence of two vicinal cysteine residues within its active site in a –Cys-Gly-
Pro-Cys- amino acid motif. These cysteines exist as either the active, reduced form (Trx(SH)₂) 
or the inactive, oxidized, disulfide form (TrxS₂). When reduced Trx(SH)₂ reacts with a target 
protein it loses two hydrogens and becomes oxidized, subsequently reducing the target protein.7 
Trx is kept in the reduced state by the flavoenzyme thioredoxin reductase, which then in turn 
utilizes NADPH to maintain its reduced state. 4 
Targets of Trx. One function of Trx is to reduce disulfide bonds on target proteins through thiol-
disulfide exchange. This involves attack by one of the reduced sulfur groups within the Trx 
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active site on the target protein disulfide. This forms a mixed disulfide between Trx and its target 
sulfur, with the other sulfur that was previously part of the target disulfide becoming a thiolate. 
The remaining thiolate group on the Trx protein then attacks this mixed disulfide, forming a new 
disulfide between the two cysteine residues of Trx and releasing the newly reduced target 
protein, as is illustrated in Figure 1.8 This process of thiol-disulfide exchange is repeated when 
Trx reductase reduces the oxidized Trx, which then allows the Trxtarget cycle to continue. 
    Targets of Trx that undergo this exchange include insulin, choriogonadotropins, 
coagulation factors, and glucocorticoid receptor, among many others.9 While the function of Trx 
in many cases is simply to keep intracellular protein disulfides reduced it can also serve as a 
regulatory protein.10 In plants it interacts with ferredoxin to regulate chloroplast photosynthetic 
enzymes, while in mammals it is used for the redox regulation of multiple transcription factors, 
including AP-1 and NFκB, to allow for communication between the nucleus and cytoplasm.11, 12 
Through a different regulatory strategy reduced Trx can also interact with ASK1 in mammals to 
prevent downstream signaling of apoptosis.13 
 Trx also has a secondary function as hydride donor, which is analogous to the function of 
NADH or NADPH. It is used in conjunction with peroxidases called peroxiredoxins to turn ROS 
such as H₂O₂ into water or alcohols.14 Trx was originally purified from Escherichia coli, where 
it was isolated as a hydrogen donor for ribonucleotide reductase, an essential enzyme that 
converts ribonucleotides to deoxyribonucleotides.15 This interaction dictates that all organisms 
that have DNA must also have Trx, and partially accounts for the essential nature and ubiquity of 
Trx throughout evolutionary history. Other utilizations of Trx as a hydride donor include protein 
repair by methionine sulfoxide reduction and assimilation of sulfur by sulfate to sulfite reduction 
in bacteria and yeast.16 
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 In addition to being a substrate for peroxiredoxins and transitively acting as an 
antioxidant through them, Trx can also quench ROS and act as a direct antioxidant. The reduced 
cysteine residues of the active site can donate electrons to ROS reducing them. The active site 
cysteines become oxidized to sulfenic acid or sulfinic acid as a result. This reaction is much 
slower than peroxiredoxin activity and as such its antioxidant capability is less. However, 
peroxidases can only act on hydrogen peroxide while Trx can quench superoxide and hydroxyl 
radical as well as hydrogen peroxide. 17     
Thioredoxin Reductase.  
Thioredoxin reductases (TR) are members of the flavoprotein family of pyridine 
nucleotide disulfide oxidoreductases. Other enzymes in this class include lipoamide 
dehydrogenase, glutathione reductase, and NADH peroxidase. TR catalyzes the NADPH 
dependent reduction of Trx and other substrates by transferring electrons through a series of 
redox centers. All organisms express some form of TR and they are categorized into two major 
classes; a low-molecular weight (Mr) class of 35 KDa that includes bacteria, archaea, and some 
eukaryotes such as plants, and a high-Mr class of 55 KDa found in many animals, including all 
mammals. Both classes exist as homodimers, with each monomer possessing a prosthetic flavin 
(FAD) redox domain as well as one or two disulfide redox centers, depending on the class. The 
reaction to reduce thioredoxin or another substrate begins with NADH binding to the enzyme 
and reducing the flavin group to FADH₂. This initiates a chain of thiol-disulfide redox reactions 
within the enzyme, ending with the reduction of the substrate. Within the classes of TR enzymes 
there are subdivisions, and while all of them reduce Trx there are slight variations in the 
mechanisms which allow for some TR enzymes to have a wider range of substrates than others.     
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High Mr Thioredoxin Reductase. High Mr TRs contain a flavin prosthetic group redox center as 
well as two disulfide redox centers, one N-terminal and one C-terminal. The N-terminal redox 
center has a conserved sequence of -Cys-Val-Asn-Val-Gly-Cys- adjacent to the flavin domain. 
This motif is identical to the redox center of the related enzyme glutathione reductase, which 
uses the redox center to directly reduce the oxidized form of the glutathione tripeptide. In TR the 
N-terminal redox center reduces the C-terminal redox center through thiol-disulfide exchange, 
which then subsequently reduces Trx. This is illustrated in Figure 2. The C-terminal center 
varies between species and allows for further classification of the TR enzyme into selenocysteine 
(Sec) containing and cysteine (Cys) only redox centers. High Mr TR is highly divergent from 
low Mr TR, which does not contain a C-terminal redox center, and the sequence identity between 
the two was found to be only 31%, while the sequence identity between high Mr TR and 
glutathione reductase is 44%. 18 
Sec containing High Mr TR.  In mammalian variants of the TR enzyme (mTR) the C-terminal 
redox center contains the rare amino acid selenocysteine (Sec). This redox active site has a 
tetrapeptide sequence of –Gly-Cys-Sec-Gly- and is conserved among all isozymes of mTR. In 
the amino acid selenocysteine, selenium replaces the sulfur atom of a cysteine residue and 
participates in redox reactions through thiol-disulfide like exchange. Mammalian TR enzymes 
with this C-terminal redox sequence are designated Type Ia. In humans there are three isozymes 
of mTR; cytosolic mTR, mitochondrial mTR, and testes-specific mTR. Cytosolic mTR is 
structurally unique in comparison to all other high Mr TR enzymes and within the literature it is 
categorized as TR1. Mitochondrial mTR is referred to as TR3 and most other high Mr TRs are 
referred to as TR3-like for their relative similarity to this variant. The reason for this distinction 
is that TR1 contains a “guiding bar” (amino acids 407-422) within its structure that prevents the 
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C-terminal redox center from moving away from the N-terminal redox center and exposing it.19 
This is important because for enzymes that lack this guiding bar, such as TR3, the N-terminal 
redox center is exposed and can interact with substrates directly, bypassing the C-terminal redox 
center. This mechanism is analogous to the mechanism of substrate reduction by glutathione 
reductase. It has been shown that TR3 and TR3-like enzymes can reduce a wide range of 
substrates including 5,5’-dithiobis(2-nitrobenzoic acid) (DTNB), lipoic acid, and selenocystine 
without the presence of the active Sec residue in their C-terminal redox center by interacting 
with the N-terminal redox center directly. However, when a mutation is made to a TR1 enzyme 
to eliminate this Sec its catalytic activity is decreased over 100 fold for all of these substrates due 
its inability to apply the alternative reduction pathway through the N-terminal redox center. 20 
Why Selenocysteine? Selenium is located directly below sulfur on the periodic table, and as such 
has many of the same chemical properties. However, because selenium is a much larger element 
with a bigger electron cloud it can both accept and donate electrons better than sulfur. While 
sulfur is a good electron donor, or nucleophile, it has less ability to accept electrons in 
comparison to selenium. Selenium can be described as a Janus-faced element, meaning that it 
can act as both as a very good nucleophile and a good electrophile, especially as part of a 
selenosulfide bond or as an Se-oxide. This allows selenium to perform chemistry in ways that 
sulfur cannot, and in the case of TR allows the selenium residue in the active site to attack one of 
the sulfurs of the Trx disulfide much faster and more reliably than a simple cysteine residue 
could. It has been shown previously that selenium not only acts as a nucleophile when it attacks 
the Trx disulfide, but it also acts as an electrophile during the thiol-disulfide exchange between 
the N-terminal and C-terminal redox centers.20 This overall chemical advantage of selenium over 
sulfur is necessary in mTR to turn over Trx quickly and efficiently.21 Selenium also has a 
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chemical advantage over sulfur in its ability to resist inactivation by oxidation. When the sulfur 
atom in a cysteine molecule is exposed to ROS it can become permanently over-oxidized to the 
sulfinic acid form. This causes the cysteine residue loses its chemical reactivity and ability to 
perform redox reactions.22 However, the Janus faced nature of selenium prevents irreversible 
oxidation of selenocysteine, which is important because Trx is essential in eliminating ROS.23 If 
TR became inactivated due to ROS it would not be able to turn over inactive Trx in the event of 
a sudden influx of ROS, which would defeat the antioxidant capabilities of the thioredoxin 
system. 
Cysteine only enzymes. High Mr TR enzymes have been discovered in Drosophila melanogaster 
(DmTR) and Plasmodium falciparum (PfTR) that do not contain any selenocysteine in their 
respective amino acid sequences. They instead utilize two cysteine residues within their C-
terminal redox centers. The structure of these redox centers differs between the two organisms, 
with D. melanogaster having a sequence of –Ser-Cys-Cys-Ser- and P. falciparum having one of 
–Gly-Cys-Gly-Gly-Gly-Lys-Cys-Gly. When oxidized the DmTR C-terminal redox center forms 
a ring of eight atoms, which is analogous to the structure of the oxidized C-terminal redox center 
of the mammalian variant of TR. DmTR is designated a Type Ib TR for this reason.24 
Alternately, the oxidized PfTR redox center forms a twenty membered ring, which among TR 
enzymes has only been discovered in apicomplexan TRs and as such is given its own category as 
a Type II TR.25 Both of these are also classified as TR3-like enzymes as both their N-terminal 
and C-terminal redox centers can reduce substrates. Drosophila melanogaster actually lacks 
glutathione reductase so glutathione is a substrate for DmTR and is reduced within the N-
terminal redox center, which is a reaction unique to insects. 26  
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Low Mr TR. While low Mr TRs and high Mr TRs are homologous, the two classes are 
structurally and mechanistically dissimilar. The Escherichia coli variant is the most widely 
studied low Mr TR so knowledge of the class is largely based on this specific enzyme. As 
mentioned previously, the low Mr TR class lacks the C-terminal redox center found in high Mr 
TRs and instead has a single disulfide redox center that directly reduces Trx via thiol-disulfide 
exchange. The mechanism of reduction begins with the binding of NADPH to its binding site. 
This induces a rotation within the enzymes structure to bring the NADPH adjacent to the flavin 
domain, which allows for rapid hydride transfer. At the same time the previously reduced 
nascent thiol redox center moves away from the flavin domain and rotates toward the surface of 
the protein to undergo thiol-disulfide exchange with the waiting Trx protein substrate.  When 
NADP+ is released the reverse rotation brings the newly oxidized thiol redox center adjacent to 
the reduced flavin domain to be reduced. This process of rotation differs from the relatively static 
mechanism of the high Mr TR.27  
High Mr TR Mechanism.  
The focus of this thesis is to solve the mechanics of electron flow between the N-terminal 
and C-terminal redox centers of PfTR, namely which cysteine of the C-terminal redox center 
undergoes attack by the N-terminal redox center and why this reaction is favorable. In order to 
solve this problem it is necessary to have an understanding of these mechanics within other high 
Mr TR variants. The sequence of the C-terminal redox center is a significant difference between 
the various types of high Mr TR enzymes and the reduction of the C-terminal center by the N-
terminal center is the focus of my studies. The mechanism of this reduction step can be studied 
and determined through enzyme assays, which is the approach I have taken here. 28 Below is a 
description of the flow of electrons from NADPH to the substrate catalyzed by TR. 
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 For all high Mr TRs the state of the enzyme immediately after reduction of a substrate 
exists as the flavin domain oxidized and hydrogen bonded to the N-terminal redox center, which 
is reduced. At this point the C-terminal redox center is an oxidized disulfide/selenylsulfide. The 
N-terminal center then undergoes thiol disulfide exchange with the C-terminal center, reducing 
it. NADPH then binds and the flavin is reduced to FADH₂. This immediately undergoes redox 
exchange with the N-terminal center, returning it to a reduced state. At this stage both redox 
centers are reduced. Trx(S₂) then binds to the C-terminal domain and undergoes thiol disulfide 
exchange. It leaves as Trx(SH)₂ and the TR enzyme is returned to its original oxidation state. It 
is important to note that the structure of TR is that of a homodimer, with the redox motifs of each 
monomer oriented as follows; C-terminal redox center, NADPH binding domain, flavin domain, 
and then N-terminal redox center. The two monomers are linked “head to tail” so that the N-
terminal redox center of one monomer is reducing the C-terminal redox center of the opposite 
monomer. The transfer of electrons between these monomers is the process that this thesis is 
concerned with. 
The mechanism of thiol/disulfide exchange of the C-terminal redox center of mTR. As previously 
stated, mTR enzymes have a C-terminal redox center sequence of –Gly-Cys495-Sec496-Gly-OH.29 
In the oxidized state (with a selenosulfide bond), this tetrapeptide forms an eight membered ring. 
This selenosulfide undergoes a thiol-disulfide exchange reaction with the N-terminal redox 
center of the opposite monomer of the homodimer. The N-terminal center is composed of an 
interchange Cys residue (CysIC) and a charge transfer Cys residue (CysCT) that form a disulfide 
bond in the oxidized state. This N-terminal disulfide is reduced by the flavin group.  This 
reduction results in a nucleophilic CysIC that attacks the electrophilic Sec residue of the vicinal 
selenosulfide bond and forms a new mixed selenosulfide bond connecting the two redox centers. 
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The thiolate of the CysCT then attacks CysIC, reforming the oxidized N-terminal disulfide bond 
and leaving the C-terminal redox center fully reduced as a thiol and a selenolate. This Sec 
residue then attacks the vicinal disulfide of Trx(S₂), acting this time as the nucleophile in the 
thiol-disulfide-like exchange. This leaves the C-terminal center oxidized and Trx reduced.28 The 
utilization of the unique chemical capabilities of selenium in this mechanism allow for rapid 
intramolecular electron exchange and resistance to inactivation by oxidation.    
DmTR C-terminal Redox Mechanism. The C-terminal redox center of DmTR is a tetrapeptide 
with an active site sequence of –Ser-Cys489-Cys490-Ser-COO⁻. When in the oxidized disulfide 
state this motif forms an eight-membered ring similar to the one formed in this complex within 
mTR. However, because this redox center lacks Sec it must somehow mimic the properties of 
selenium within one of the Cys residues to allow rapid electron transfer to occur. The enzyme 
does this by positioning a positively charged histidine (HisH+) residue adjacent to the Cys489 of 
the disulfide. The positive charge of the His induces a negative charge on the Cys489 sulfur, 
which creates a dipole within the disulfide and gives the sulfur of Cys490 a partial positive 
charge. By doing this the Cys490 is made electrophilic and can undergo attack by the CysIC 
residue of the N-terminal redox center. In the literature this mechanism has been deemed 
“electrophilic activation”.30 After the C-terminal redox center has been reduced it can undergo 
thiol-disulfide exchange with Trx(S2) by attacking the disulfide bond of Trx(S2) with Cys490. 
This reaction is made favorable by the presence a Ser residue adjacent to Cys490 that stabilizes its 
sulfur as a thiolate through hydrogen bonding after reduction. A thiolate is a much better 
nucleophile than the thiol group that would form in the absence of the Ser residue and allows the 
C-terminal redox center to reduce the substrate at a more rapid rate.29 Through these mechanisms 
Cys 490 is made chemically similar to Sec during the redox reactions involving the C-terminal 
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center, allowing the enzyme to perform the same chemistry as mTR without the need for 
selenium.  
PfTR Proposed Mechanism. The C-terminal redox center of PfTR is structurally very different 
from the other two variants discussed, but it is hypothesized in this thesis that the redox 
mechanisms are similar. The active site sequence of this enzyme is –Gly-Cys534-Gly-Gly-Gly-
Lys-Cys541-Gly-COO-, which forms a twenty-membered ring in the oxidized state. The presence 
of the disulfide introduces this motif to undergo a transition from and intrinsically disordered 
state to a β-turn-β motif, which is stabilized by hydrogen bonding between the amino acids of the 
ring. Deletion or substitution of any of the amino acids of the sequence decreases the catalytic 
activity of the enzyme.25 The unique structure of this C-terminal redox center allows this enzyme 
to specifically reduce its native substrate, the Plasmodium falciparum variant of Trx (PfTrx).31 
Although this ring is much larger than those of DmTR and mTR, I propose that it undergoes 
electrophilic activation in a way similar to the mechanism of DmTR. Like DmTR, a positively 
charged histidine residue (His509) is located adjacent to the C-terminal redox center of PfTR. I 
hypothesize that this residue hydrogen bonds with the more N-terminal cysteine residue of the 
redox center disulfide, Cys535, to induce a positive charge on more C-terminal cysteine, Cys540, 
priming it to be attacked by the N-terminal redox center. This is illustrated in Figure 7. These 
assigned roles for the cysteine residues are based on the mechanisms of mTR and DmTR.28, 32    
Inhibition of Hydrogen Bonding 
Thio effect. The substitution of sulfur in place of phosphate bound oxygen is a tool mainly used 
to determine the mechanisms of RNA phosphodiester bond cleavage by ribozymes and DNA 
phosphodiester cleavage by phosphodiesterases like RNase A.33, 34 As sulfur is directly below 
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oxygen on the periodic table it less electronegative, larger, more readily polarizable, and has a 
lower pKa. When oxygen is replaced with sulfur within a phosphate group many properties of 
that group can be altered, including its hydrogen bonding capabilities, the geometry of the 
phosphorane intermediate, its leaving group property, and its affinity to metal ions.35 The 
substitution of sulfur at the different oxygen positions within a phosphate group will typically 
decrease the Kcat of the enzyme being studied and allow for insights into the mechanism of 
catalysis. This change is expressed as a ratio of kO/kS, where O is the native oxygen substrate and 
S is the sulfur analog, and this ratio is called the “thio effect”.36 A common example of this is the 
substitution of sulfur for oxygen at a non-bridging oxygen atom of a phosphate group. Typically 
the phosphorous atom is activated for nucleophilic attack from an enzyme by hydrogen bonding 
between the non-bridging oxygen and a positively charged hydrogen bond donor. The lower 
basicity of sulfur in comparison to oxygen results in a lower ability of the sulfur atom to engage 
in hydrogen bonding or to formally accept a proton. This results in less activation of the 
phosphorous atom of a phosphorothioate compared to a phosphorous atom of a phosphate, 
resulting in a slower rate of reaction.37   
Seleno Effect. This concept can be extended to the replacement of a native sulfur atom in a 
disulfide bond with the element below it on the periodic table, selenium. The differences 
between Se and S can be used to explore mechanisms in the same way that O to S substitution 
can. This concept has been used to account for differences in hydrogen bonding between Cys and 
Sec residues within the active sites of enzymes due to the lower pKa of Sec compared to Cys. 
Within the context of TR, the Cys residue of the C-terminal redox center that is not attacked 
during redox exchange undergoes hydrogen bonding with an adjacent histidine residue, which in 
the case of DmTR and likely PfTR induces a dipole in the disulfide and allows the Cys to 
	   14 
become protonated easily upon reduction. This same mechanism was proposed for the PfTR 
mechanism.25 When this activating C-terminal Cys in DmTR was replaced with Sec the rate of 
the thiol disulfide exchange reaction was decreased by 10-fold.30 The substitution of Se in place 
of S in the redox center disulfide lowered the pKa of the residue and in doing so decreased the 
effect of hydrogen bonding by an adjacent positively charged histidine residue, and resulted in a 
less polarized selenosulfide bond. This made the disulfide less likely to undergo attack by the N-
terminal redox center and lowered the overall rate of thiol disulfide exchange. It is hypothesized 
that a similar substitution of the activating CysSec in PfTR will result in a comparable 
decrease in activity due to this seleno effect. The mechanism by which this occurs is shown in 
Figure 8. 
 The purpose of this project is to determine the mechanism of redox exchange between the 
N-terminal and C-terminal redox centers of PfTR. In order to isolate which cysteine residue of 
the C-terminal redox center is being attacked, as well as identify if hydrogen bonding is 
occurring to polarize the disulfide, the seleno effect was utilized through substitution of the 
cysteine residues with selenocysteine. It is hypothesized that an electrophilic activation 
mechanism exists in the C-terminal redox center of PfTR through hydrogen bonding between 
His509 and Cys535, which induces a partial positive charge on Cys540 and makes it more prone to 
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MATERIALS AND METHODS 
Materials. Vent DNA polymerase, NdeI, SapI, T4 DNA ligase, E. coli ER2566 competent cells, 
and chitin-agarose beads were purchased from New England Biolabs (Ipswich, MA). GSH -
sepharose 4 Fast Flow, benzamidine sepharose, and 2′-4′-ADP-sepharose resins were obtained 
from GE Healthcare (Waukesha, WI). Solvents for peptide synthesis were purchased from EMD 
Biosciences (San Diego, CA). Fmoc-amino acids were purchased from Synpep Corp (Dublin, 
CA).  Fmoc-Sec-Xanthene was obtained as a gift from Dr. Steven Flemer38. Resins for solid-
phase synthesis were purchased from Applied Biosystems (Foster City, CA). All other chemicals 
were purchased from either Sigma-Aldrich (Milwaukee, WI) or Fisher Scientific (Pittsburgh, 
PA). The HPLC system was from Shimadzu with a Symmetry® C18 -5 µm column from Waters 
(4.6 x 150mm). A Voyager-DETM PRO Workstation (Applied Biosystems) was used for mass 
spectral analysis of peptide samples. All enzyme kinetic assays were performed on a Cary50 
UV-vis spectrophotometer (Cary, Walnut Creek, CA) and were conducted at room temperature.  
Production and Purification of Semisynthetic PfTR mutants and PfTRΔ7. The production of 
enzymes A and B of Table 2, as well as the PfTRΔ7 that was used in the peptide assays, was 
achieved through intein-mediated peptide ligation39. First a truncated PfTR construct, PfTRΔ7, 
was formed by through PCR amplification of the full length wild type PfTR DNA template. The 
upstream primer that introduced a NdeI restriction site (sequence: 5'-
ACAGACATATGGGATCCTGC-AAA-3′) and a downstream primer which introduced a seven 
amino acid deletion, the insertion of a Cys residue, and a SapI endonuclease restriction site 
(sequence: 5′-ACAGCCGCTCTTCAGCAACCACCTTT-3′) were used. PCR was done on an 
Eppendorf Mastercycler using Vent DNA polymerase. The amplified sequence was then digested 
with NdeI and SapI and shuttled into the pTYB1 expression vector from New England Biolabs. 
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Ligation of the product was then conducted using T4 DNA ligase. The resulting plasmid was 
used to produce the PfTRΔ7-intein-chitin binding domain fusion protein in E. coli ER2566 cells 
with Sce VAM intein (both provided by New England Biolabs).  
 These cells were grown in Terrific broth medium with niacinamide, riboflavin, and 
pyridoxine supplementation (20 mg/L each). The cell culture, containing 0.2 µg/mL ampicillin, 
was grown at 37 °C until the OD600 reached∼0.6. The cells were then cooled to 20 °C, and 
IPTG was added to induce expression to a final concentration of 0.5 mM, with subsequent 
incubation done at 20 °C overnight on a shaker. The cells were harvested by centrifugation (9000 
rpm in a Beckman J2-21 preparatory centrifuge for 10 min at 4 °C) following overnight 
incubation. The harvested bacterial cell pellet was normalized in chitin buffer A [50 mM MOPS 
and 150 mM NaCl (pH 7.0)] followed by cell lysis via pulse sonication. The lysed slurry was 
then pelleted via centrifugation (12000 rpm in a Beckman J2-21 preparatory centrifuge for 1 h at 
4 °C), and the cleared lysate was loaded onto a chitin−agarose column pre-equilibrated with 
chitin buffer A. The intein-chitin binding domain fused to PfTR allowed it to bind to the resin 
with high specificity. The loaded PfTR protein was further washed with 0.5 L of chitin buffer A 
followed by additional washing with 0.5 L of high-salt chitin buffer B [50 mM MOPS and 500 
mM NaCl (pH 7.0)]. Chitin buffer B was then added to the resin containing the bound protein to 
convert it to slurry, which was then transferred to two 50 mL conical tubes.  
The semisynthetic PfTR enzymes (A and B of Table 2) were produced via ligation of 
desired synthetic peptides to the truncated PfTRΔ7 containing a C-terminal thioester reactive 
group. Proteins containing a C-termimal thioester can be ligated to peptides that have an N-
terminal Cys residue to form an amide bond 39. Simultaneous cleavage of the fusion protein and 
ligation with synthetic peptide were achieved by addition of a cleavage cocktail consisting of 120 
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mM N-methyl mercaptoacetamide (NMA) and the desired synthetic peptide in chitin buffer B 
(pH 8.0−8.5). The cleavage and ligation reaction was done at room temperature overnight with 
constant shaking. Following overnight incubation, the resin/chitin slurry was poured back onto 
the column and the liberated semisynthetic enzyme was eluted via gravity flow and washing with 
chitin buffer B. The semisynthetic enzyme was concentrated and buffer exchanged with buffer C 
[10mM NaCl, 10mMTris-EDTA, and 20 mM βME (pH 8.0)] via ultrafiltration (Amicon Ultracel 
30 kDa cut off filters). It was then loaded by gravity onto a pre-equilibrated 2′,4′-ADP-sepharose 
column (20 mL). After the sample had been extensively washed with buffer C, the semisynthetic 
PfTR enzyme was eluted off the 2′,4′-ADP-sepharose column with high-salt buffer [10 mM Tris-
EDTA, 1 M NaCl, and 20 mM βME (pH 8.0)]. The fractions containing PfTR were confirmed 
by spectrophotometry and SDS−PAGE, pooled, and then buffer exchanged via ultrafiltration 
with storage buffer [50 mM potassium phosphate, 500 mM NaCl, and 1 mM EDTA (pH 8.0)]. 
The concentration of each PfTR semisynthetic enzyme was determined through spectral analysis 
via the absorbance maximum of the flavin at 460 nm (ε = 22.6 mM−1 cm−1, representing the 
dimer). 
The truncated enzyme (PfTRΔ7) was produced for use in kinetic peptide substrate assays 
by cleaving the PfTRΔ7−intein fusion protein in the presence of NMA, without peptide present. 
After cleavage from the chitin−agarose column, pooled fractions of PfTRΔ7 were concentrated 
by ultrafiltration and loaded onto a Sephacryl-S200 column that had been pre-equilibrated with 
50mM potassium phosphate, 500 mM NaCl, and 1 mM EDTA (pH 8.0). TR-positive fractions 
eluted off the column and were then pooled and concentrated using the methods above. 
Syntheses of Cysteine Peptides. All peptides were synthesized with a Burrell Model 75 wrist-
action shaker (Pittsburgh, PA). Peptides were synthesized on a 0.3 mmole scale using 2-
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cholorotridylchloride resin (1.33 mmol/g loading) at 3 eq. excess. For each peptide synthesis the 
resin was first swelled in dichloromethane (DCM) for 30 min. and then the first amino acid was 
coupled using 1.1 eq. Fmoc-AA-OH dissolved in 5 mL of a 2.22% N-methylmorpholoine 
(NMM)/ 97.7% DCM (0.2 M NMM) solution and shaken for one hour. The resin was then 
washed four times using DCM and capped with 10 mL of 8:1:1-DCM:Methanol:NMM and 
shaken for fifteen minutes. Following this the resin was washed 4X with DCM and 4X with 
dimethylformamide (DMF). Deprotection of the N-Fmoc protecting group was carried out using 
two 10-min agitations with a solution of 20% piperidine/ 80% DMF. Success of all deprotections 
and amino acid couplings were monitored qualitatively using a ninhydrin test40.  Elongation of 
the peptides used standard Fmoc SPPS chemistry with 2 eq. (equivalents relative to peptide 
synthesis scale in mmoles) HATU and 2 eq. Fmoc-AA-OH in 5 mL of a 4.40% NMM/ 95.6% 
DMF (0.5 M NMM) solution, shaken for one hour41. Following a final deprotection and 4X wash 
with DCM these peptides were cleaved from the resin with a cocktail consisting of 96:2:2 
trifluoroacetic acid(TFA):triisoproprylsilane(TIS):H2O for 2 hr. The solution was blown into a 
conical using nitrogen gas and the resin was washed four times using DCM. The cleavage 
cocktails were dripped into cold, anhydrous diethyl ether to precipitate the peptide and then 
pelleted by centrifugation. The pellet was allowed to dry and then redissolved in 1 mL of the 
96:2:2 TFA:TIS:H2O cocktail, dripped into anhydrous diethyl ether and centrifuged to pellet 
(2X). The peptide was then dissolved in a minimal amount of a water/acetonitrile mixture and 
lyophilized. This process is illustrated in Figure 3. 
Syntheses of Selenocysteine Peptides. The amino acid Fmoc-Sec-xanthene was used as the 
selenocysteine residue for the two Sec peptides. The resin and procedure for these peptides was 
the same as described previously, with one exception. When coupling Fmoc-Sec-Xan and all 
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other amino acids following it in the synthesis the conditions were 2 eq. Fmoc-AA-OH and 4 eq. 
HOAT dissolved in 5 mL of 1.88% diisopropylcarbodiimide (DIC)/98.1% DMF (94 uL/4.906 
mL) shaken for three hours for Sec or one hour for any other amino acid. The cleavage and 
swelling of the resin used the same procedure as for the cysteine amino acids.  
Oxidation of Wild Type Peptide. During the synthesis of the wild type peptide Fmoc-Cys-S-Tmp 
was used as the cysteine building block in both locations along the peptide. After the final 
coupling but before the final deprotection and cleavage from the resin this peptide was oxidized. 
To do this 0.1 M NMM (55 µL) in 5% dithiothreitol (DTT)/ 95% DMF was first added to the 
resin and shaken for 5 min. (3X) to deprotect the STMP group42. The resin was then washed 4X 
with DMF and 4X with DCM. The success of the deprotection was tested using a solution of 
Ellman’s reagent and DCM on a sample of the resin beads. The resin was then washed 4X with 
DMF. 2 eq. of N-chlorosuccinimide dissolved in 5 mL of DMF was then added to the resin and 
shaken for 15 min. to for the disulfide bond. After washing 4X with DMF and then DCM the 
resin was re-tested to confirm the oxidation. The final Fmoc group was then deprotected and the 
peptide was cleaved from the resin. This process is illustrated in Figure 4. 
Oxidation of the Homocysteine Peptides. Unlike the other peptides synthesized, the two 
homocysteine containing peptides were oxidized post cleavage from the resin. CLEAR-OX™ 
resin was used to induce disulfide formation of the disulfide bond. This resin has 5,5'-dithiobis-
(2-nitrobenzoic acid) (DTNB/ Ellman’s reagent) bound to a solid resin, was used to form the 
disulfide bond. The CLEAR-OX™ resin was loaded at a 0.21 meq./g of resin ratio compared to 
the peptide quantity, swelled in DCM for 40 min, then washed with DCM, DMF, methanol, 
deionized water, and degassed 1:1 100 mM ammonium bicarbonate:acetonitrile 3 times each.. 
The solid peptides (2 and 3) were then dissolved in 1 mL/6 mg of 1:1 acetonitrile (ACN): 0.1 M 
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ammonium bicarbonate (degassed). The solution was added to the resin and agitated for two 
hours. Following agitation by shaking the solution was blown out of the vessel with N₂ gas, 
diluted with water, and lyophilized. It was subsequently discovered that some DNTB and TNB 
anion had detached from the resin and contaminated the sample. These impurities were removed 
by binding the sample to DEAE-Sepharose resin (diethylaminoethanol). The impurities are 
negatively charged at this pH, while the peptide is positively charged and unable to bind the 
resin.  The sample was dissolved in ammonia bicarbonate buffer, pH 7.5, and then added to a 
small amount of resin that had been equilibrated with the same buffer. After agitating the sample 
with the resin for 30 min, the resin slurry was transferred to a microcentrifuge tube fitted with a 
filter. The eluent with the peptide was then collected by centrifugation and lyophilized. The 
oxidation process is shown in Figure 5.  
Oxidation of Selenocysteine Peptides. The oxidation of the Sec peptides occurs during their 
cleavage from the resin. The xanthene protecting group was cleaved by the highly acidic 
TFA:TIS:H₂O cleavage cocktail. The free oxygen in solution then allows the highly reactive 
selenium to spontaneously oxidize with the cysteine residue forming the seleno-thiol bond. This 
is illustrated in Figure 6. 
Confirmation of Peptide Sequences. The purity, sequence, and oxidation of all synthesized 
peptides were confirmed through mass spectral analysis using a Voyager-DETM PRO 
Workstation (Applied Biosystems) based on calculated molecular weights for the peptides. These 
are shown in Figures 15, 16, 17, 18, and 19.  
Enzyme Assays. All assays were done using a spectrophotometer at A340. The parameters for all 
assays were 500 µL total volume, 1 mM EDTA, 150 µM NADH, 100 mM KPO₄ buffer, 15 nM 
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PfTRΔ7 truncated enzyme, and varying synthesized peptide concentrations. The assays 
measured the consumption of NADH at A340, which was then used to calculate enzyme-peptide 
activity using Beer’s Law. 
Failed Oxidation of Peptides. Multiple copies of all synthesized peptides were made, but due to 
the nature of the enzyme assay not all could be used due to the oxidative reagents utilized to 
cyclize the disulfide or selenosulfide bond. Initially peptides I, II, and III of Table 1 were 
oxidized using a molar equivalent of benzeneseleninic acid. This reagent was later determined to 
give artificial activity to the enzyme assays. An extraction was attempted using 1:1 Phenol : 
Chloroform, but not all of the contaminant was removed and some peptide was lost. Another 
oxidation was done on peptide I only, after resynthesizing it, using DTNB in solution. This also 
resulted in contamination and artificial activity, and again extraction using phenol-chloroform 
was unsuccessful. Oxidation was then attempted again on resynthesized peptides II and III using 
CLEAR-OX™ resin. This was also found to contaminate the samples with DTNB, so extraction 
was done with DEAE-Sepharose resin as described above, and was successful. The alternate 
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RESULTS AND DISCUSSION 
Electrophilic Activation: Isolation of N-terminal to C-terminal thiol disulfide exchange 
 In nature Cys orthologs of Sec enzymes have been shown to possess mechanisms to 
increase S-nucleophilicity that allow for increased rates of thiol disulfide exchange, to 
compensate for the absence of the more nucleophilic selenium.29 Selenium is also a more 
electrophilic atom than sulfur, and so it stands to reason that Cys orthologs of Sec enzymes in 
which selenium acts as an electrophile have another mechanism to emulate this superior 
electrophilicity.43 In mTR and other Sec TR enzymes selenium in the C-terminal redox center 
acts as both an electrophile during N-terminal to C-terminal redox exchange and a nucleophile 
during its attack on a substrate.28, 44 In order to catalyze the same reaction, TR enzymes that lack 
Sec, such as DmTR and PfTR, must have mechanisms that change the properties of sulfur at 
these steps to emulate the chemistry of selenium. Previous work investigating N-terminal to C-
terminal disulfide exchange in DmTR provides evidence that the disulfide bond of the C-
terminal redox center is polarized by an adjacent histidine residue, inducing a partial positive 
charge on one of the sulfurs and priming it for attack by the N-terminal redox center. This 
mechanism was termed “electrophilic activation”.30 Although the structures of the C-terminal 
redox center differs between DmTR and PfTR I hypothesize that the two enzymes use a similar 
mechanism of electrophilic activation to compensate for the absence of selenium in the 
thiol/disulfide exchange step that occurs between the N- and C-terminal redox centers, as 
illustrated in Figure 7. 
 To investigate this intramolecular mechanism I exploited the structure of PfTR to create 
an intermolecular reaction instead. The C-terminal redox center of PfTR is conveniently located 
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as the final eight amino acids of the enzyme’s sequence. It is also present on the exterior of the 
protein, as it needs to interact with substrates. This allowed me to chemically synthesize 
peptides, either of the wild type sequence or mutants, and assay them in a solution containing a 
truncated variant of the enzyme (PfTRΔ7) which does not contain the C-terminal redox center. 
The peptide binds to PfTRΔ7 as a substrate and is reduced by the N-terminal redox center as it 
would be in the native enzyme, consuming NADPH in the process, as shown in Figure 10. By 
creating mutant peptides that have had a cysteine replaced with either selenocysteine or 
homocysteine I was then able to investigate the mechanism of this thiol disulfide exchange step. 
The synthesized peptides are illustrated below in Table 1. This method of assaying a truncated 
enzyme with a peptide as a substrate has also been used to investigate the C-terminal redox 
center mechanism of DmTR and mTR. 21, 30 
 To provide an alternate method of analyzing the exchange mechanism, semisynthetic 
enzymes of PfTR were also created. These were made by synthesizing mutant peptides with the 
same sequences as peptides IV and V (sans the N-terminal glycine residue) and ligating them to 
the truncated PfTRΔ7 enzyme using methods previously published by the Hondal lab.25 This 
allowed me to determine the activity of these mutant redox centers on two natural substates of 
PfTR; Trx and selenocystine. The results of these assays are shown in Table 2 and Figures 13 
and 14.  
Assessing the impact of Cys540Sec substitution 
 In mTR and other selenium containing TRs Sec is located at the more C-terminal position 
within the redox center, and in DmTR the most C-terminal cysteine residue has been shown to 
perform the same function that Sec does in mTR.45 Based on this it is hypothesized that the most 
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C-terminal cysteine residue of the C-terminal redox center of PfTR, Cys540, takes on the role that 
Sec plays in mTR. If this hypothesis is correct, then the sulfur atom of Cys540 is attacked during 
thiol/disulfide exchange and then subsequently initiates nucleophilic attack onto the disulfide 
bond of the substrate. To test this hypothesis, a mutant peptide (peptide IV in Table 1) with a 
Cys540Sec substitution was synthesized. When assayed this peptide resulted in a significant 
increase in PfTRΔ7 activity when compared to the WT (peptide I), as illustrated in Figure 11. 
The effect of this substitution was also analyzed in a full length PfTR enzyme with its natural 
substrates through semisynthesis. The semisynthetic analog of this mutant peptide, ligated 
enzyme A, had Trx and selenocystine activity ~75 and ~25 fold higher than ligated enzyme B, 
which has Cys535Sec substitution. The reason for this change in catalytic function is that by 
replacing sulfur with the more electrophilic selenium the N-terminal redox center has a better 
target for thiol disulfide exchange and the rate is consequently increased, as shown in Figure 9. 
The rate increase at this substitution position provides evidence that Cys540 is indeed the residue 
that is attacked during the intramolecular N-terminal to C-terminal redox exchange. 
The question that then presents itself is that if Sec in this position does increase catalytic 
function, why is it not included in the wild type enzyme? There are four selenoproteins coded for 
by P. falciparum, so the organism has the correct “machinery” available to incorporate this 
amino acid into proteins.46 A possible reason is that when a Cys540Sec substitution is 
introduced the hydrogen peroxidase activity of PfTR goes up 6-fold, likely due to selenium’s 
ability to not be irreversibly inactivated by oxidation as sulfur is.23, 25, 47 Its increased ability to 
process hydrogen peroxidase could alter the redox balance of the cell and negatively affect some 
processes of the organism. Another possible reason is that PfTR is specialized to reduce PfTrx, 
hence its unique C-terminal structure. Although it lacks Sec, PfTR has similar activity reducing 
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PfTrx to human TR reducing human Trx, while having very little activity on human Trx or those 
of other species.48 The specialization of PfTR’s C-terminal redox center is important for 
differentiation between PfTrx, its host’s human Trx, and its vector’s A. gambiae Trx, so if Sec 
was introduced into this site it could negatively affect the enzyme’s ability to differentiate. The 
PfTR C-terminal redox center could possibly be exploited as a potential anti-malarial drug target 
due to this unique specialization, but further research would need to be done.     
Assessing Cys535Sec substitution: The Seleno Effect 
While the results of peptide 4 did confirm that Cys540 is the residue undergoing attack by the N-
terminal redox center, it did nothing to prove the electrophilic activation hypothesis. To test this 
hypothesis I synthesized peptide V, which has a Cys535Sec substitution. If we assume that it is 
Cys540 that is undergoing attack, then the electrophilic activation hypothesis predicts that it must 
be Cys535 that is interacting with an adjacent positive charge and polarizing the disulfide. If this 
mechanism was not present in the enzyme then conventional chemical logic would assume that a 
Cys535Sec substitution would result in an increase in catalytic activity, as selenium is a better 
leaving group than sulfur due to its lower pKa.21 As illustrated in Figure 11 and Table 1 this is 
not the case, with peptide V actually having a ~5-fold decrease in activity compared to the wild 
type peptide. This leads to the assumption that not only is there an electrophilic activation 
mechanism present in the wild type peptide that increases its activity, but also that selenium 
substitution for sulfur inhibits this mechanism in some way. In the semisynthetic enzyme assays 
ligated enzyme B had significantly lower activity than ligated enzyme A, which provides further 
evidence for this inhibition.  I hypothesize that this inhibition is due to a “seleno-effect” on the 
hydrogen bonding between Cys535 and His509. Due to the differential effects seen in the two types 
of selenium substitution, the data is consistent with an electrophilic activation mechanism in the 
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reduction of the wild type peptide that increases its activity compared to not being activated due 
to polarization of the disulfide. In the semisynthetic enzyme assays ligated enzyme B had 
significantly lower activity than ligated enzyme A, which provides further evidence for the 
proposed electrophilic activation mechanism.   
 The term “seleno-effect” is a derivative of the thio-effect, a phenomenon commonly 
utilized in studying phosphodiesterases. In the thio-effect the substitution of sulfur in place of a 
non-bridging oxygen within the DNA phosphate backbone disturbs hydrogen bonding between a 
binding protein and the phosphate group and subsequently results in a measurable decrease in 
activity.35 This disruption of hydrogen bonding is due to the lower pKa of sulfur compared to 
oxygen, resulting in a less stable bond to a positively charged residue on the enzyme.34   
The periodic column of chalcogens includes, in descending order, oxygen, sulfur, and 
selenium (as well as tellurium and polonium which are not present in organisms). These 
elements share common qualities, such as having six valence electrons, which leads to them 
having a similar role within organic molecules. However, many qualities of these atoms change 
as you go down the column, including increased size, decreased electronegativity, and decreased 
pKas. The seleno-effect employs this change in basicity in the same way that the thio-effect 
utilizes the difference in basicity between oxygen and sulfur, by disturbing a hydrogen bond that 
would otherwise serve a role within the enzyme.  
In the case of PfTR, it is the hydrogen bond that between Cys535 and His509 that will be 
disturbed. By replacing Cys535 with Sec in peptide 5 the lower basicity of selenium will not allow 
it to hydrogen bond as strongly to His509 as sulfur would. Following the electrophilic activation 
hypothesis, it is this hydrogen bond that is polarizing the disulfide in the wild type and inducing 
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a partial positive charge on Cys540, making it more electrophilic and prone to thiolate attack. So 
by eliminating this bond the selenosulfide bond does not become polarized and Cys540 incurs no 
positive charge, decreasing the rate of attack by the N-terminal redox center. This is shown in 
Figure 8. 
Assessing the importance of the C-terminal disulfide position 
 One of the features of the PfTR C-terminal redox center that I explored was the 
importance of the position of the active disulfide in relation to the rest of the enzyme. To do this 
I synthesized mutant peptides (II and III) with a homocysteine residue substituted for cysteine 
and assayed them with the truncated enzyme (PfTRΔ7) to assess their activity. Homocysteine 
substitution, which when compared to cysteine has an additional methylene unit (3 Å) between 
the α-carbon and the thiol group, results in a peptide that forms a 21-membered ring when 
oxidized. This seemingly minute change to the native 20-membered ring results in 3-fold loss of 
activity when compared to the WT- peptide (I), as shown in Table 1 and Figure 12. Previous 
research has shown that cysteinehomocysteine substitution in the C-terminal redox center of 
semisynthetic PfTR enzymes results in a significant decrease in activity, and my research 
supports these findings through the alternate method of peptide substrate assays.25 There are two 
possible mechanisms for this decreased activity 1) this change in disulfide positioning affects the 
rate of attack by the C-terminal thiolate on Trx or 2) the mutant peptide is an inferior substrate 
for N-terminal attack and thiol disulfide exchange. As the N-terminalC-terminal redox 
exchange is the rate limiting step of the enzyme the latter seems to be a more likely option. This 
is consistent with the proposed electrophilic activation of the disulfide by His509. By substituting 
homocysteine for cysteine the disulfide has a slightly altered location in the mutant peptide 
relative to this His509 residue, which disturbs the hydrogen bonding between His509 and Cys535, 
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thereby inhibiting electrophilic activation. This disruption of His509-Cys535 hydrogen bonding 
will occur regardless of which cysteine residue is substituted with homocysteine, as the shift in 
disulfide location will be roughly equal for substitution at either location. The results of the 
assays reflect this, with very little difference in activity between the two homocysteine mutant 
peptides (II and III).         
Failed oxidations of peptides 
 The most difficult part of this research was not any of the processes involving assays or 
peptide synthesis, but rather the oxidation of the synthesized peptides. In order to prepare the 
peptides for assays they must be in the cyclized, oxidized form with either a disulfide or a 
selenosulfide bond between the second and seventh residues. There are many common reagents 
for this process, but the problem is than many of these same reagents are targets for TR. Even 
when using PfTRΔ7 they can be reduced by the N-terminal redox center and give artificial 
activity to the assay. Luckily, the Sec containing peptides (IV and V) will auto-oxidize after the 
protecting group has been removed from the selenium residue, so there was no difficulty 
oxidizing those two peptides. The first oxidizing reagent that I used was benzeneseleninic acid to 
oxidize peptides I, II, and III. After we realized that the activities for all of these assays were far 
too high we concluded that the oxidizing agent was contaminating the peptides and causing 
artificial activity. Extraction of the benzeneseleninic acid from the peptides with phenol-
chloroform did not manage to completely remove the contaminant so I discarded those samples 
and moved on. The next reagent that I tried was DTNB on peptide I only, which had the same 
result as the diphenyl diselenide in that it gave artificial activity and was very difficult to extract. 
This time I opted to extract the DTNB with HPLC, which did yield some fractions of pure 
peptide sample. However, these fractions did not contain enough peptide to perform full assays 
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and the sample was again discarded. After the DTNB failure I decided to oxidize my new 
samples of peptides II and II with Clear-OxTM resin, which has DTNB bound to a solid resin and 
hypothetically would allow me to remove the peptide after oxidation without any contamination. 
This did not prove to be the case as the peptide solution was yellow after removal from the resin, 
which is a telltale sign of TNB anion contamination. An extraction using HPLC was then 
attempted, but as with the previous sample, the fractions containing the peptide were very dilute 
and did not yield enough peptide after lyophilization to run a full assay. I then synthesized a 
peptide I that would allow for on-resin oxidation, so that any oxidizing agents used could simply 
be washed off of the peptide resin prior to cleavage. By utilizing Fmoc-Cys-S-Tmp instead of the 
acid labile Fmoc-Cys-(Trt)OH   I was able to remove the S-Tmp protecting group with the mild 
reducing agent DTT, which does not cleave the peptide from the resin.42 I then treated resin with 
N-Chlorosuccinimide to oxidize the cysteine residues and then washed it out with DMF and 
DCM. The normal procedure was then followed to cleave the peptide from the resin. This 
procedure worked well and no contaminants showed up in the assays or on mass spectrometry.  
The only problem was that while oxidizing on resin worked well for peptide I, peptides II and III 
contain homocysteine residues, which is not available as an Fmoc amino acid with an S-Tmp 
protecting group. We decided to synthesize these peptides one final time and oxidize them as we 
did before with the Clear-Ox resin.  As expected, there was some TNB contamination following 
the oxidation. To solve this problem we passed the peptide solution over a DEAE resin, an anion 
exchange resin that binds the negatively charged TNB contaminants and lets the positively 
charged peptides flow through. This was done multiple times until all of the peptide solution ran 
clear and no characteristic TNB/DTNB peak at 412 nm was visible on the spectrophotometer. 
The assays of peptides II and III were successful following this treatment. 
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Conclusion. 
 I have investigated the C-terminal redox center of PfTR through peptide substrate assays 
and semisynthesis. My results provide evidence that Cys540 is attacked by the N-terminal redox 
center to initiate intramolecular thiol-disulfide exchange. This reaction is made favorable by an 
electrophilic activation mechanism on the Cys535-Cys540 disulfide bond through hydrogen 
bonding with His509, resulting in N-terminal attack on Cys540. The substitution of Cys535 with Sec 
results in catalytic rate reduction, which I contend is evidence of a “seleno-effect” that inhibits 
His509 hydrogen bonding and inhibits electrophilic activation. My results also demonstrate the 
importance of the disulfide ring size on this catalytic mechanism as well as multiple methods for 
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TABLES 
Table 1: Activities of synthesized peptides assayed with PfTRΔ7 
a These assays resulted in linear trends not suitable to plot with Michaelis-Menten 
 
Table 2: Kinetics of semisynthetic enzymes with Trx and selenocystine 
Ligated 
Enzyme 
Sequence Trx Kcat  
(min-1) 




A PfTR-CGGGKUG 561 ± 39 18 ± 5 672 ± 73 84 ± 25 










Specific activity at 5 
mM peptide (mol 
NADPH/min/mol TR) 
I GC535GGGKC540G 20 320 ± 30 4.8 ± 0.9 167 ± 4 
II GCGGGKhCG 21 a a 31 ± 3 
III GhCGGGKCG 21 155 ± 12 12 ± 1 47 ± 11 
IV GCGGGKUG 20 a a 289 ± 36 
V GUGGGKCG 20 114 ± 32 12 ± 4.6 36 ± 18 










Figure 1: Thiol-disulfide exchange between Trx and a target protein. A) A reduced Trx cysteine 
residue in the active site attacks the oxidized disulfide of a target protein. B) Formation of a 
mixed disulfide transition state between Trx and its target. C) Exchange is complete; the target is 
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Figure 2: Mammalian TR homodimer with redox centers shown. High MW TR enzymes 
contain three redox centers in each monomer; a bound flavin domain, an N-terminal disulfide 
redox center and a C-terminal disulfide redox center, as well as an NADPH binding domain. 
Electrons flow through these redox centers to ultimately allow the C-terminal redox center to 
reduce the substrate Trx. First, NADPH bind to its binding domain and reduces the flavin 
domain. This flavin then reduces the disulfide of the N-teminal redox center. This redox center 
then reduces the C-terminal redox center of the opposite monomer through thiol disulfide 
exchange. In this depiction the right side of the enzyme is shown  in the reduced configuration 
while the left side is shown oxidized.  
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Figure 3: General solid phase Fmoc peptide synthesis procedure. Solid phase peptide synthesis 
is done on a resin that bind to the most C-terminal amino acid of the peptide. Each amino acid 
is protected by an Fmoc group on its amino end. After the first amino acid is coupled to the 
resin this Fmoc group is deprotected using piperidine. The next amino acid in the sequence (C--
>N) is then added to the resin with a coupling reagent and a peptide bond is formed. This cycle 
of deprotection and coupling is repeated until the peptide sequence is complete. The peptide is 
then cleaved from the resin using strong acid and precipitated.   






















Figure 4: On resin oxidation of Peptide I. The cysteine residues of the peptide are protected 
with Stmp. A cocktail of 0.1 M NMM in 1:20 DTT:DMF is used to cleave the Stmp groups. 
Two molar equivalents of N-chlorosuccinamide is then used to form the disulfide between the 
two cysteine residues. This method allows for disulfide formation to be done while the peptide 
is still on the resin due to the lack of acid used in the protecting group cleavage.  






















Figure 5: Off resin oxidation of homocysteine peptides (II and III). Cysteine and homocysteine 
are both protected by an acid labile Trt group. Upon cleavage of the peptide from the resin 
these groups were also removed. The peptides were then oxidized by passing them over a 
ClearOxTM resin with bound DTNB oxidizing agent. This formed a disulfide within the peptide, 
oxidizing it. Some TNB anions leaked off of the resin and contaminated the sample, so the 
sample was then run through an anion exchange resin that removed the contaminating anions.    
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Figure 6: Off resin oxidation of selenocystine peptides (IV and V). The cysteine residues were 
protected by an acid labile Trt group, while the selenocysteine residue was protected by an acid 
labile xanthene group. Upon cleavage of the peptide from the resin these groups were also 
removed. Selenium then reacted with free oxygen in the solution to auto-oxidize the peptide, 
forming a seleno-sulfide bond. Selenocysteine containing peptides were the easiest to oxidize 
because they do not need any oxidizing reagent other than free oxygen in solution. 
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PfTR-GC1GGGKC2G (WT) 
Figure 7: Proposed PfTR C-terminal redox center electrophilic activation mechanism. Hydrogen 
bonding between the positively charged His509 and the sulfur (S1) of Cys535 (C1) draws the 
electrons of the disulfide bond toward S1, which then consequently induces a partial positive 
charge in the sulfur (S2) of Cys540 (C2). This makes S2 more electrophilic and prone to attack by 
the negatively charged attacking cysteine residue of the N-terminal redox center (CysIC).   














Figure 8: Mechanism of seleno effect rate reduction when Cys535 is substituted with Sec in C-
terminal redox center of PfTR. When Cys535 is replaced with Sec the positive charge of His509 
cannot induced a dipole within the selenosulfide bond. This is because selenium has a lower pKa 
than sulfur and will not hydrogen bond as readily to the histidine residue. The sulfur (S2) of 
Cys540 (C2) therefore no longer has an induced partial positive charge and is not a good 
electrophile for the attacking N-terminal cysteine residue (CysIC). This reduces the rate of thiol-
disulfide exchange (kex) and the overall catalytic rate of PfTR.    
 
 




Figure 9: PfTR rate increase as a result of C-terminal redox center Cys540 to Sec substitution. 
Cys540 is the proposed residue that undergoes attack to initiate thiol disulfide exchange between 
the N-terminal and C-terminal redox centers. In this model Cys540 has been replaced by Sec. 
Selenium is a much better nucleophile than sulfur, making it a better target of attack for the N-












Figure 10: Redox cycle of full length PfTR with Trx as a substrate and PfTRΔ7 with a peptide 
substrate. In order to isolate the exchange between the N-terminal and C-terminal redox centers 
PfTRΔ7 was assayed with a peptide substrate with the structure of the C-terminal redox center. 
This allowed the consumption of NADPH to directly reflect this redox exchange. In the full 






















Figure 11:	  Enzyme assays of peptides 1, 4, and 5 with PfTRΔ7. This Michaelis-Menten plot 
shows the Kcat of PfTRΔ7 with peptides 1, 4, and 5 as substrates plotted against peptide 
concentration. These illustrate the difference in Sec substitution at the attacked Cys540, resulting 
in an increase in activity, versus a Sec substitution at the activating Cys535, resulting in a decrease 
due to the disturbance of electrophilic activation by the seleno-effect. These are plotted with the 
wild type peptide to show relative activity. 





















Figure 12: Enzyme assays of peptides 1, 2, and 3 with PfTRΔ7. The Michaelis-Menten plot 
shows the Kcat of PfTRΔ7 with peptides 1, 2, and 3 as substrates plotted against peptide 
concentration. This shows the difference in activity between the wild type peptide and the two 
homocysteine mutant peptides. Homocysteine substitution at either location results in a similar 
reduction in PfTRΔ7 activity.  
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Figure 13: Enzyme assay plot of ligated enzymes A and B with selenocystine as a substrate. 
These Michealis-Menten curves show the how Sec for Cys substitution increases enzyme activity 
towards selenocystine at Cys540 and decreases it at Cys535. This is due to the increased 
electrophilicity of selenium over sulfur when acting as an electrophile at Cys540 and the 
inhibition of PfTR’s electrophilic activation mechanism through the seleno effect at Cys535. 
PfTR-GCGGGKUG has approximately 30 fold greater activity than PFTR-GUGGGKCG. 
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Figure 14: Enzyme assay plot of ligated enzymes A and B with thioredoxin as a substrate. The 
Michaelis-Menten curves show how enzyme activity following Cys540Sec substitution is much 
greater than the activity following Cys535Sec substitution with Trx as a substrate. PfTR-
GCGGGKUG has approximately 75 fold greater activity than PfTR-GUGGGKCG. 
 
 












Figure 15: Mass spectral analysis of Peptide I. The molecular weight of Peptide I when oxidized is 
636 (MW = 638 when reduced). The sample was analyzed through mass spectrometry using direct 
infusion in positive ESI. The plot shows peaks at both the MW and one half of the MW (318) for the 
doubly charged peptide.  
	  











Figure 16: Mass spectral analysis of Peptide II. The molecular weight of Peptide II when oxidized is 
650 (MW = 652 when reduced). The sample was analyzed through mass spectrometry using direct 
infusion in positive ESI. The plot shows peaks at both the MW and one half of the MW (325) for the 
doubly charged peptide.  
	  










Figure 17: Mass spectral analysis of Peptide III. The molecular weight of Peptide III when oxidized 
is 650 (MW = 652 when reduced). The sample was analyzed through mass spectrometry using direct 
infusion in positive ESI. The plot shows peaks at both the MW and one half of the MW (325) for the 
doubly charged peptide.  
	  










Figure 18: Mass spectral analysis of Peptide IV. The molecular weight of Peptide IV when oxidized 
is 684 (MW = 686 when reduced). The sample was analyzed through mass spectrometry using direct 
infusion in positive ESI. The plot shows peaks at both the MW and one half of the MW (342) for the 
doubly charged peptide.  
	  










Figure 19: Mass spectral analysis of Peptide V. The molecular weight of Peptide V when oxidized is 
684 (MW = 686 when reduced). The sample was analyzed through mass spectrometry using direct 
infusion in positive ESI. The plot shows peaks at both the MW and one half of the MW (342) for the 
doubly charged peptide.  
	  
